ZYME

Zymeworks
$23.00
+$0.14 (+0.61%)Jul 27, 2026
3.9FairMoatMint rating

MoatMint rates Zymeworks (ZYME) 3.9 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 3.1 out of 10.

Key metrics

The numbers that frame ZYME today
Market cap
$1.68B
P/E (TTM)
-16.4
EV / FCF
-22.1
Gross margin
100%
EV / Sales
20.9
ROIC
-31.6%
Div yield
0%
Debt / equity
1.6
52wk Low
$11.51
52wk High
$29.75

ZYME stock rating

How ZYME scores on quality, value, growth, momentum and financial health
3.9out of 10
Fair overallFair business, expensive priceTop 61% of ~5,000 US stocks
QualityFair3.1/10
GrowthFair2.4/10
MomentumGood7.7/10
ValueFair2.6/10
Financial HealthGood6.2/10

Growth

Revenue and earnings trend for ZYME
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ZYME
Is Zymeworks a good buy?
Hold. Zymeworks has excellent momentum, but weak quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Zymeworks is selling at a high price.
What is the market capitalization of ZYME?
Zymeworks's market capitalization is $1.68B.
What is the P/E ratio for ZYME stock?
Zymeworks's current P/E ratio is -16.4.
What is the 52-week high for ZYME stock?
The 52-week high for Zymeworks is $29.75. The current close of $23.00 is 22.7% below that high.
What is the 52-week low for ZYME stock?
The 52-week low for Zymeworks is $11.51. The current close of $23.00 is 99.8% above that low.
Does ZYME stock pay dividends?
Zymeworks does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ZYME?
Zymeworks's Debt / Equity ratio is 1.61.